Induction of bronchus-associated lymphoid tissue is an early life adaptation for promoting human B cell immunity
- PMID: 37460638
- PMCID: PMC10529876
- DOI: 10.1038/s41590-023-01557-3
Induction of bronchus-associated lymphoid tissue is an early life adaptation for promoting human B cell immunity
Abstract
Infants and young children are more susceptible to common respiratory pathogens than adults but can fare better against novel pathogens like severe acute respiratory syndrome coronavirus 2. The mechanisms by which infants and young children mount effective immune responses to respiratory pathogens are unknown. Through investigation of lungs and lung-associated lymph nodes from infant and pediatric organ donors aged 0-13 years, we show that bronchus-associated lymphoid tissue (BALT), containing B cell follicles, CD4+ T cells and functionally active germinal centers, develop during infancy. BALT structures are prevalent around lung airways during the first 3 years of life, and their numbers decline through childhood coincident with the accumulation of memory T cells. Single-cell profiling and repertoire analysis reveals that early life lung B cells undergo differentiation, somatic hypermutation and immunoglobulin class switching and exhibit a more activated profile than lymph node B cells. Moreover, B cells in the lung and lung-associated lymph nodes generate biased antibody responses to multiple respiratory pathogens compared to circulating antibodies, which are mostly specific for vaccine antigens in the early years of life. Together, our findings provide evidence for BALT as an early life adaptation for mobilizing localized immune protection to the diverse respiratory challenges during this formative life stage.
© 2023. The Author(s), under exclusive licence to Springer Nature America, Inc.
Conflict of interest statement
Figures













Comment in
-
Formation of bronchus-associated lymphoid tissue (BALT) for early life immune protection.Nat Immunol. 2023 Aug;24(8):1228-1229. doi: 10.1038/s41590-023-01573-3. Nat Immunol. 2023. PMID: 37474657 No abstract available.
-
The case for BALT in human respiratory immunity.Nat Immunol. 2023 Aug;24(8):1220-1221. doi: 10.1038/s41590-023-01566-2. Nat Immunol. 2023. PMID: 37488430 No abstract available.
References
-
- Mohr E & Siegrist C-A Vaccination in early life: standing up to the challenges. Current Opinion in Immunology 41, 1–8 (2016). - PubMed
-
- PrabhuDas M et al. Challenges in infant immunity: implications for responses to infection and vaccines. Nat Immunol 12, 189–194 (2011). - PubMed
-
- Franca TT et al. CD40 ligand deficiency: treatment strategies and novel therapeutic perspectives. Expert Rev Clin Immunol 15, 529–540 (2019). - PubMed
-
- Crotty S Follicular helper CD4 T cells (TFH). Annu Rev Immunol 29, 621–663 (2011). - PubMed
Methods-Only References
Publication types
MeSH terms
Grants and funding
- U01 AI100119/AI/NIAID NIH HHS/United States
- R01 AI100119/AI/NIAID NIH HHS/United States
- AI168634/AI/NIAID NIH HHS/United States
- AI142288/AI/NIAID NIH HHS/United States
- K23 AI141686/AI/NIAID NIH HHS/United States
- U19 AI128949/AI/NIAID NIH HHS/United States
- S10 RR027050/RR/NCRR NIH HHS/United States
- P01 AI042288/AI/NIAID NIH HHS/United States
- U01 AI168634/AI/NIAID NIH HHS/United States
- AI106697/AI/NIAID NIH HHS/United States
- P01 AI106697/AI/NIAID NIH HHS/United States
- AI141686/AI/NIAID NIH HHS/United States
- AI100119/AI/NIAID NIH HHS/United States
- U01 HL145547/HL/NHLBI NIH HHS/United States
- S10 OD020056/OD/NIH HHS/United States
- AI128949/AI/NIAID NIH HHS/United States
- P30 CA013696/CA/NCI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Research Materials